Related references
Note: Only part of the references are listed.Combination of Osteopontin with Peritumoral Infiltrating Macrophages is Associated with Poor Prognosis of Early-Stage Hepatocellular Carcinoma after Curative Resection
Wenwei Zhu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin
S. Kale et al.
ONCOGENE (2014)
Treatment of gastric cancer
Michele Orditura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Impact of tumour associated macrophages in pancreatic cancer
Ainhoa Mielgo et al.
BMB REPORTS (2013)
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
Atsushi Nashimoto et al.
GASTRIC CANCER (2013)
Tumour-infiltrating macrophages and clinical outcome in breast cancer
S. M. A. Mahmoud et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients
Hyuk-Chan Kwon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Damya Laoui et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Hiroshi Kurahara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1α up-regulation and MMP9 activation
Gang Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Immunohistochemical Expression of Osteopontin in Gastric Cancer
Motohiro Imano et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
Mabel Ryder et al.
ENDOCRINE-RELATED CANCER (2008)
Osteopontin: regulation in tumor metastasis
Philip Y. Wai et al.
CANCER AND METASTASIS REVIEWS (2008)
Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells
Jiasen Cheng et al.
CANCER RESEARCH (2007)
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers
Hideki Sakaguchi et al.
CANCER LETTERS (2007)
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
Chun-Ying Wu et al.
GUT (2007)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435
Lalita A. Shevde et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer
Z Hu et al.
CLINICAL CANCER RESEARCH (2005)
Osteopontin expression correlates with melanoma invasion
YW Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data
I Chou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Role of osteopontin in tumour progression
SR Rittling et al.
BRITISH JOURNAL OF CANCER (2004)
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
HW Pan et al.
CANCER (2003)
Share Paper
